Compare UP & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UP | INVA |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | N/A | 2004 |
| Metric | UP | INVA |
|---|---|---|
| Price | $0.61 | $19.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $36.80 |
| AVG Volume (30 Days) | ★ 3.3M | 949.2K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.96 |
| EPS | N/A | ★ 1.52 |
| Revenue | ★ $757,468,000.00 | $388,521,000.00 |
| Revenue This Year | $174.46 | $13.23 |
| Revenue Next Year | N/A | $8.58 |
| P/E Ratio | ★ N/A | $12.98 |
| Revenue Growth | N/A | ★ 10.14 |
| 52 Week Low | $0.59 | $16.52 |
| 52 Week High | $3.50 | $22.76 |
| Indicator | UP | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 38.16 | 38.84 |
| Support Level | $0.61 | $19.30 |
| Resistance Level | $0.78 | $20.27 |
| Average True Range (ATR) | 0.09 | 0.52 |
| MACD | 0.02 | -0.13 |
| Stochastic Oscillator | 6.02 | 20.54 |
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.